Goldman Sachs analyst Asad Haider assumed coverage of Merck (MRK) with a Buy rating and price target of $103, down from $129. Following the recent selloff, the shares are now trading at levels ...

Germany's Merck KGaA has said it needs to double the productivity of its R&D operations, with the aim of launching a new product every 18 months on average, to boost its pharma business.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE: MRK) stands against other stocks that Jim Cramer discussed recently. On Wednesday, Jim Cramer, the host of Mad Money ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After a disappointing ELF 2024 season, Frankfurt Galaxy wants to regain its former strength. The motto for the upcoming ...

Ex-wife's murder: Gujarat HC acquits man, cites gaps in prosecution case AHMEDABAD: A murder that had gripped the city with its gruesome details has ended in acquittal. Gujarat HC overturned a ...

Eli Lilly's manufacturing plant in Limerick. President Trump said he would shortly unveil tariffs on pharmaceutical imports. (Paulo Nunes dos Santos/Bloomberg News) Stocks in drugmakers sold off ...